title: Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study).
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Samantha
authors.initials: S
authors.lastname: Fraser-Bell
authors.affiliation: Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
authors.forename: Lyndell L
authors.initials: LL
authors.lastname: Lim
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Anna
authors.initials: A
authors.lastname: Campain
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. Electronic address: HM@cantab.net.
authors.forename: Hemal
authors.initials: H
authors.lastname: Mehta
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Christine
authors.initials: C
authors.lastname: Aroney
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Jaclyn
authors.initials: J
authors.lastname: Bryant
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Ji
authors.initials: J
authors.lastname: Li
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Ophthalmology Department, Australian School of Advanced Medicine, Macquarie University, Sydney, NSW, Australia.
authors.forename: Godfrey J
authors.initials: GJ
authors.lastname: Quin
authors.affiliation: Lions Eye Institute, Centre for Ophthalmology and Visual Science, University of Western Australia, Australia.
authors.forename: Ian L
authors.initials: IL
authors.lastname: McAllister
authors.affiliation: Save Sight and Eye Health Institute, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
authors.forename: Mark C
authors.initials: MC
authors.lastname: Gillies
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004343:Drug Implants; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D013997:Time Factors; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D004343:Drug Implants; D005938:Glucocorticoids; D000068258:Bevacizumab; D003907:Dexamethasone